GSK Names New President Of GSK Japan

Published: 04-Feb-2010

GlaxoSmithKline (GSK) has appointed Philippe Fauchet as president of GSK Japan. Mr Fauchet will report to Marc Dunoyer, who takes the new role as chairman of GSK Japan. Mr Dunoyer will continue to take overall leadership responsibility for GSK’s pharmaceuticals business across the Asia Pacific/Japan region.

Mr Fauchet has joined GSK from Sanofi Aventis where he worked as senior vice president for business development. He joined Sanofi in 1996, and headed up the Eastern Europe region from 1997, before becoming vice president of Eastern Europe for Sanofi-Synthelabo in 1999. Mr Fauchet took over as head of Sanofi-Synthelabo’s Japanese operations in June 2001 and was appointed as senior vice president of pharmaceuticals operations, Japan in May 2005.

Marc Dunoyer, president of Asia Pacific and chairman of GSK Japan, said: “The depth of knowledge and experience Philippe gained through previous roles in Japan, his general business and commercial acumen and his proven leadership skills make him ideally suited to drive the growth of this key business. Over the next five years we have the potential to launch between 30 and 40 products in Japan and I look forward to working with Philippe to maximise this opportunity.”

Tell your friend about this article